These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 28640954)
1. The Ussing Chamber Assay to Study Drug Metabolism and Transport in the Human Intestine. Kisser B; Mangelsen E; Wingolf C; Partecke LI; Heidecke CD; Tannergren C; Oswald S; Keiser M Curr Protoc Pharmacol; 2017 Jun; 77():7.17.1-7.17.19. PubMed ID: 28640954 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum. Michiba K; Maeda K; Kurimori K; Enomoto T; Shimomura O; Takeuchi T; Nishiyama H; Oda T; Kusuhara H Drug Metab Dispos; 2021 Jan; 49(1):84-93. PubMed ID: 33087448 [TBL] [Abstract][Full Text] [Related]
3. Human enteroid monolayers as a potential alternative for Ussing chamber and Caco-2 monolayers to study passive permeability and drug efflux. Streekstra EJ; Keuper-Navis M; van den Heuvel JJMW; van den Broek P; Stommel MWJ; Bervoets S; O'Gorman L; Greupink R; Russel FGM; van de Steeg E; de Wildt SN Eur J Pharm Sci; 2024 Oct; 201():106877. PubMed ID: 39154715 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Ussing Chamber and Caco-2 Model in Evaluation of Intestinal Absorption Mechanism of Compounds from Different BCS Classifications. Tian D; Yang Y; Zhang H; Du H; Zhou H; Wang T Drug Metab Bioanal Lett; 2023; 16(2):105-112. PubMed ID: 37711012 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique. Sjöberg Å; Lutz M; Tannergren C; Wingolf C; Borde A; Ungell AL Eur J Pharm Sci; 2013 Jan; 48(1-2):166-80. PubMed ID: 23103351 [TBL] [Abstract][Full Text] [Related]
6. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs. Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036 [TBL] [Abstract][Full Text] [Related]
7. Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue. Haslam IS; O'Reilly DA; Sherlock DJ; Kauser A; Womack C; Coleman T Biopharm Drug Dispos; 2011 May; 32(4):210-21. PubMed ID: 21416475 [TBL] [Abstract][Full Text] [Related]
8. Functional Assessment of Intestinal Tight Junction Barrier and Ion Permeability in Native Tissue by Ussing Chamber Technique. Hempstock W; Ishizuka N; Hayashi H J Vis Exp; 2021 May; (171):. PubMed ID: 34125105 [TBL] [Abstract][Full Text] [Related]
9. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model. Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous Prediction of Intestinal Absorption and Metabolism Using the Mini-Ussing Chamber System. Kondo S; Miyake M J Pharm Sci; 2019 Jan; 108(1):763-769. PubMed ID: 30389567 [TBL] [Abstract][Full Text] [Related]
11. Strategies for absorption screening in drug discovery and development. Bohets H; Annaert P; Mannens G; Van Beijsterveldt L; Anciaux K; Verboven P; Meuldermans W; Lavrijsen K Curr Top Med Chem; 2001 Nov; 1(5):367-83. PubMed ID: 11899103 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of an Ussing Chamber System Equipped with Rat Intestinal Tissues to Predict Intestinal Absorption and Metabolism in Humans. Guan C; Yang Y; Tian D; Jiang Z; Zhang H; Li Y; Yan J; Zhang C; Chen C; Zhang J; Wang J; Wang Y; Du H; Zhou H; Wang T Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):639-652. PubMed ID: 35733077 [TBL] [Abstract][Full Text] [Related]
14. Enteroids to Study Pediatric Intestinal Drug Transport. Streekstra EJ; Keuper-Navis M; van den Heuvel JJMW; van den Broek P; Stommel MWJ; de Boode W; Botden S; Bervoets S; O'Gorman L; Greupink R; Russel FGM; van de Steeg E; de Wildt SN Mol Pharm; 2024 Oct; 21(10):4983-4994. PubMed ID: 39279643 [TBL] [Abstract][Full Text] [Related]
15. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices. Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168 [TBL] [Abstract][Full Text] [Related]
16. Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue. Brück S; Strohmeier J; Busch D; Drozdzik M; Oswald S Biopharm Drug Dispos; 2017 Mar; 38(2):115-126. PubMed ID: 27516347 [TBL] [Abstract][Full Text] [Related]
17. Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)-but how? Kaneko K; Miyasaka R; Hayman R PLoS One; 2022; 17(5):e0268067. PubMed ID: 35588130 [TBL] [Abstract][Full Text] [Related]
18. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine. Akazawa T; Yoshida S; Ohnishi S; Kanazu T; Kawai M; Takahashi K Drug Metab Dispos; 2018 Nov; 46(11):1497-1506. PubMed ID: 30135242 [TBL] [Abstract][Full Text] [Related]
19. Intestinal transport as a potential determinant of drug bioavailability. Nauli AM; Nauli SM Curr Clin Pharmacol; 2013 Aug; 8(3):247-55. PubMed ID: 23343017 [TBL] [Abstract][Full Text] [Related]
20. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]